Friday 6 November 2026 Export WST’s income statement to Excel — free account

West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024.

Revenue: +8.69%
EPS: +56.7%
Free cash flow: +12.3%
Total debt: +0.10%

Quarter to September 2026, against a year earlier

392.97 15.81 −3.87%

Follow WST

Alert me

Market cap: $27.3B
P/E: 43.8×
Fwd P/E: 48.1×
Dividend yield: 0.22%
F-score: 8/9
Altman Z: 13.89
Beneish M: −2.79
Dividend safety: 100/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

West Pharmaceutical Services, Inc. (WST) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, West Pharmaceutical Services, Inc. (WST) trades at a P/E ratio of 43.8×. Over the past ten years it has ranged from 24.7× (November 2022) to 74.4× (September 2020); the current reading is higher than 48% of that period. That is above the Medical Instruments & Supplies industry median of 30.3× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/WST/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="West Pharmaceutical Services, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/WST/metrics/pe-ratio">West Pharmaceutical Services, Inc. (WST) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	40.3×	(16.99%)
FY2024	48.5×	11.06%
FY2023	43.7×	46.70%
FY2022	29.8×	(43.35%)
FY2021	52.6×	(12.96%)
FY2020	60.4×	31.40%
FY2019	46.0×	31.31%
FY2018	35.0×	(27.87%)
FY2017	48.5×	13.16%
FY2016	42.9×	(5.27%)

Period	P/E ratio	Change
Sep 2026	41.3×	(9.39%)
Jun 2026	45.6×	36.86%
Mar 2026	33.3×	(17.26%)
Dec 2025	40.3×	4.27%
43 more quarters	Free account

Against its own ten years

Low 24.7× High 74.4×

Ten-year median 44.2×

Current reading's percentile 45

Company	P/E ratio
BAX Baxter International Inc. compare	n/m
COO The Cooper Companies, Inc. compare	21.7×
RMD ResMed Inc. compare	21.7×
ALGN Align Technology, Inc. compare	23.1×
WST West Pharmaceutical Services, Inc.	43.8×
ALC Alcon compare	58.4×
MDLN Medline Inc. compare	58.4×
BDX Becton, Dickinson and Company compare	64.1×
SOLV Solventum Corporation compare	97.3×
Medical Instruments & Supplies industry median	30.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

West Pharmaceutical Services, Inc. (WST) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on WST

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on WST

Stockrow Weekly